TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM NEW
Total 13F shares
5,093,985
Share change
-216,373
Total reported value
$26,226,626
Price per share
$5.15
Number of holders
20
Value change
-$878,582
Number of buys
8
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q3 2017

As of 30 Sep 2017, TRILLIUM THERAPEUTICS INC - COM NEW was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,093,985 shares. The largest 10 holders included AWM Investment Company, Inc., NEA Management Company, LLC, Cormorant Asset Management, LLC, Tekla Capital Management LLC, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, New Leaf Venture Partners, L.L.C., Sectoral Asset Management Inc, VICTORY CAPITAL MANAGEMENT INC, and Candriam Luxembourg S.C.A.. This page lists 20 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.